Search
for
Sort by
Research 211–240 of 1000+
- Modulating the Antioxidant Response for Better Oxidative Stress-Inducing Therapies: How to Take Advantage of Two Sides of the Same Medal?
- Activation of AR Sensitizes Breast Carcinomas to NVP-BEZ235's Therapeutic Effect Mediated by PTEN and KLLN Upregulation
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- Flightless I exacerbation of inflammatory responses contributes to increased colonic damage in a mouse model of dextran sulphate sodium-induced ulcerative colitis
- Impact of Clinical Response on Different Approved Doses in Japan and the United States
- Expanding the therapeutic landscape of sCD83 in hair disorders
- Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- A Randomised Controlled Trial Comparing the Therapeutic Efficacy and Safety of Oral Cyclosporine and Oral Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata
- Drug Discovery Today: Therapeutic Strategies - 2006 Editorial
- RANK as a therapeutic target in cancer
- Response of alopecia areata of the beard to oral tofacitinib
- Phototherapy as a Useful Therapeutic Option in the Treatment of Diphenylcyclopropenone-induced Vitiligo
- Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
- Journal of Population Therapeutics and Clinical Pharmacology
- iTRAQ-based quantitative proteomics revealing the therapeutic mechanism of a medicinal and edible formula YH0618 in reducing doxorubicin-induced alopecia by targeting keratins and TGF-β/Smad3 pathway
- Oral zinc sulphate in treatment of patients with thallium poisoning: A clinical therapeutic trial
- Oral zinc sulphate in treatment of patients with thallium poisoning: A clinical therapeutic trial
- Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study
- Macrophages in Skin Wounds: Functions and Therapeutic Potential
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies
- Stem cell-derived exosomes: emerging therapeutic opportunities for wound healing
- Allopregnanolone mediates the exacerbation of Tourette-like responses by acute stress in mouse models
- Stem Cell-Derived Extracellular Vesicles: Promising Therapeutic Opportunities for Diabetic Wound Healing
- Extra-nasal odorant receptors: molecular mechanisms and therapeutic implications
- Protein S-Palmitoylation as Potential Therapeutic Target for Dermatoses
- Fucoidan treatment reverses hair loss and inhibits inflammatory responses in a mouse model of androgenetic alopecia
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- Acrodermatitis continua resistant to etanercept: Therapeutic challenge and Unfortunate outcome